BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 10510532)

  • 1. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease.
    de Almeida EA; de Oliveira EI; Lopes JA; Almeida AG; Lopes MG; Prata MM
    Rev Port Cardiol; 2007 Mar; 26(3):235-43. PubMed ID: 17549981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA; Prata MM
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
    Kelleher CL; McFann KK; Johnson AM; Schrier RW
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease].
    Idrizi A; Barbullushi M; Strakosha A; Kodra S; Thereska N; Zaimi E; Gjyzari A; Petrela E
    G Ital Nefrol; 2007; 24(6):595-9. PubMed ID: 18278763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ambulatory 24-hour blood pressure monitoring of children and young adults with autosome dominant polycystic kidney degeneration].
    Geberth S; Zeier M; Schmidt KG; Mandelbaum A; Ritz E
    Z Kardiol; 1992; 81 Suppl 2():21-4. PubMed ID: 1514306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.
    Fick-Brosnahan GM; Belz MM; McFann KK; Johnson AM; Schrier RW
    Am J Kidney Dis; 2002 Jun; 39(6):1127-34. PubMed ID: 12046022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
    Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
    Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease.
    Seeman T; Dusek J; Vondrák K; Bláhová K; Simková E; Kreisinger J; Dvorák P; Kyncl M; Hríbal Z; Janda J
    Physiol Res; 2004; 53(6):629-34. PubMed ID: 15588131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
    Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autosomal dominant hereditary polycystic kidney disease].
    Kapras J; Stekrová J; Zidovská J; Merta M; Brdicka R
    Cas Lek Cesk; 1995 Aug; 134(16):521-3. PubMed ID: 7553752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.
    Seeman T; Dusek J; Vondrichová H; Kyncl M; John U; Misselwitz J; Janda J
    Blood Press Monit; 2003 Jun; 8(3):107-10. PubMed ID: 12900587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.